Dynamic Technology Lab Private Ltd Invests $2.03 Million in Encompass Health Co. (NYSE:EHC)

Dynamic Technology Lab Private Ltd bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 21,940 shares of the company's stock, valued at approximately $2,026,000.

A number of other large investors have also bought and sold shares of EHC. MassMutual Private Wealth & Trust FSB grew its position in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the period. CBIZ Investment Advisory Services LLC increased its position in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new stake in shares of Encompass Health in the 4th quarter worth about $46,000. V Square Quantitative Management LLC boosted its stake in Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after purchasing an additional 177 shares during the last quarter. Finally, Signaturefd LLC increased its holdings in Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after purchasing an additional 125 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.10% of the company's stock.

Remove Ads

Encompass Health Stock Performance

Shares of NYSE EHC traded down $1.26 during mid-day trading on Thursday, hitting $101.94. The company had a trading volume of 483,248 shares, compared to its average volume of 656,223. The stock's 50-day moving average price is $99.51 and its 200-day moving average price is $97.93. The company has a market capitalization of $10.27 billion, a price-to-earnings ratio of 22.86, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 1 year low of $78.53 and a 1 year high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, sell-side analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. Encompass Health's dividend payout ratio (DPR) is currently 15.25%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on EHC shares. KeyCorp lifted their target price on Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research report on Monday, February 10th. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com lowered shares of Encompass Health from a "buy" rating to a "hold" rating in a research note on Thursday, April 3rd. Royal Bank of Canada reiterated an "outperform" rating and set a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. Finally, Barclays upped their price objective on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.